The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Beyond BMI - Phenotyping the Obesities
Open accessAbstract
For more than a decade, researchers in the field of obesity have debated the value of the BMI as the most common and convenient index for classifying the obese condition. The implications of using BMI are profound. The cut-off points of BMI of <18.5 kg/m2, 18.5-24.9 kg/m2, 25.0-29.9 kg/m2, 30.0-34.9 kg/m2, 35.0-39.9 kg/m2 and 40.0+ kg/m2 define categories usually referred to as underweight, normal weight, overweight (pre-obese) and obese (grades I, II and III). These cut-off points therefore define the number of individuals falling into each category which, in turn, tells us the prevalence of obesity on the planet. However, the essence of obesity is adipose tissue in the body (not a relationship of height and weight), so the BMI can only serve as an indirect estimate of obesity. Obesity is defined as an excess accumulation of body fat, and this excess fat is normally conceived as an indicator of poor health and, in turn, constitutes a risk factor for a range of diseases including diabetes, ischaemic heart disease, hyperlipidaemia, sleep apnoea, arthritis and others [1]. The BMI is therefore a measure of the number of people in the world who are in poor health, and who possess a condition that is threatening to their longevity or their quality of life. This has implications for who should be concerned (about themselves) and who should be a candidate for treatment (by others). Since the risk of early death or a life of disease prompts actions by public health authorities or medical agencies, the economic consequences are profound. If BMI provides a faulty quantification of who is at risk, then the personal, social and economic consequences are serious.However, BMI is an anthropometric concept and therefore serves only as a surrogate measure for fatness. Although BMI correlates with percentage body fat, the correlation between both parameters is not sufficiently accurate to truthfully reflect the amount of fat in the body in a particular subject. Therefore if fatness is the true risk factor for longevity and health, then BMI is only an approximation and is therefore inadequate.For several years some reviewers have argued for the adoption of direct measures of body fat [2,3,4]. The advantages arising from accurate measures of fat itself should be evident in research, prevention and management of obesity-dependent co-morbidities, and should result in more truthful and valid relationships underlying the aetiology of obesity and its physical and social consequences. What are the major problems associated with the continued use of BMI? Clearly the BMI categories (defined by the cut-off boundaries noted above) can only be approximate indications of the characteristics of individuals contained by these categories. However, for years there have always been advocates of using other indices to identify obesity, such as skin-fold thickness, waist circumference and waist-to-hip ratio (WHR). Indeed the WHR has been used to identify the so-called android and gynoid morphological types and their relationship with obesity-related co-morbidities. With the development of devices and equipment to more accurately measure body fat, including DEXA, air-displacement plethysmography (BodPod), bioimpedance and body scanning procedures - replacing the cumbersome underwater weighing -, it has become possible to more easily classify individuals according to the degree of bodily adipose tissue and to measure the consequences independently of BMI. This approach has also drawn attention to the function of non-adipose tissue - that is, fat-free mass or lean mass - and the contribution made by fat-free mass to physiological functioning, pathology and well-being. Should we persist with BMI (because of its convenience) when there now exist more accurate measures of fatness and fat distribution? Decisions concerning the adoption of particular BMI cut-off points (for defining obesity) appear to have been established on the basis of data collected by the Metropolitan Life Insurance Company more than 50 years ago. These statistical tables apparently showed that health began to deteriorate at a BMI above 25 kg/m2. Therefore this BMI value came to be regarded as the upper level for ‘normal weight' based on associated markers of health. This decision has implications for the absolute numbers of people considered to be at risk of ill health or premature death as well as on the development of preventive and therapeutic strategies both at individual and collective level.One good reason to replace BMI with alternative measures would be if the BMI failed to accurately reflect the likelihood of early death or vulnerability to various diseases. One area of investigation in which BMI has retained its value is epidemiology; for the obvious reason that height and weight are easy (sometimes deceptively easy) measures to take when participant numbers are usually in the hundreds and may reach several thousands of individuals. However, accuracy cannot be guaranteed
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome — An allostatic perspective
Virtue, S., & Vidal-Puig, A. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.12.006 · Cited by 1,013
Association of Weight Status With Mortality in Adults With Incident Diabetes
Carnethon, M. R., De Chavez, P. J. D., Biggs, M. L., Lewis, C. E., Pankow, J. S., Bertoni, A. G., Golden, S. H., Liu, K., Mukamal, K. J., Campbell-Jenkins, B., et al. (2012) · JAMA · doi:10.1001/jama.2012.9282 · Cited by 567
Fogelholm, M. (2010) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00653.x · Cited by 517
Gluttony, sloth and the metabolic syndrome: a roadmap to lipotoxicity
Unger, R. H., & Scherer, P. E. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2010.01.009 · Cited by 436
Gómez‐Ambrosi, J., Silva, C., Galofré, J. C., Escalada, J., Santos, S., Gil, M. J., Valentí, V., Rotellar, F., Ramírez, B., Salvador, J., et al. (2011) · Obesity · doi:10.1038/oby.2011.36 · Cited by 264
Self-citation
Cited by
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
European Guidelines for Obesity Management in Adults
Yumuk, V., Tsigos, C., Fried, M., Schindler, K., Busetto, L., Micic, D., & Toplak, H. (2015) · Obesity Facts · doi:10.1159/000442721 · Cited by 3,432
Blundell, J. E., Baker, J. L., Boyland, E., Blaak, E., Charzewska, J., de Henauw, S., Frühbeck, G., Gonzalez-Gross, M., Hebebrand, J., Holm, L., et al. (2017) · Obesity Facts · doi:10.1159/000455952 · Cited by 1,945
Self-citationBray, G. A., Frühbeck, G., Ryan, D. H., & Wilding, J. P. H. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00271-3 · Cited by 1,036
Self-citationKalinkovich, A., & Livshits, G. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.09.008 · Cited by 882
Metadata
- Authors
- Blundell, J. E., Dulloo, A. G., Salvador, J., Frühbeck, G., & on behalf of the EASO SAB Working Group on BMI, G.
- Venue
- Obesity Facts
- Publisher
- S. Karger AG
- Published
- 2014
- Volume
- 7
- Issue
- 5
- Pages
- 322-328
- ISSN
- 1662-4025 (ISSN-L)
- 1662-4033
- OpenAlex
- W2071539264
- Cited by
- 197
- References
- 5
- FWCI
- 7.77
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Beyond BMI - Phenotyping the Obesities. https://app.cochat.ai/papers/10.1159/000368783
- The paper
- Blundell, J. E., Dulloo, A. G., Salvador, J., Frühbeck, G., & on behalf of the EASO SAB Working Group on BMI, G. (2014). Beyond BMI - Phenotyping the Obesities. Obesity Facts. https://doi.org/10.1159/000368783
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.